Autologous Fecal Therapy
Infectious Disease of Digestive Tract
About this trial
This is an interventional prevention trial for Infectious Disease of Digestive Tract focused on measuring Fecal microbiota therapy
Eligibility Criteria
Inclusion Criteria:
Healthy Adults 18-70 years of age-
Exclusion Criteria:
history of allergic reaction to beta-lactam antimicrobials; any non-topical antimicrobial exposure or tube feeds as a primary source of nutrition in the past six months; pregnant or risk of becoming pregnant during the study period; gastroenteritis in the last 3 months; incontinent of stool; prior resection or alteration of the stomach; small bowel, or colon; unwillingness to receive an enema/FMT; known colonization with an MDRO; anticipated change in diet or medications, or elective surgery, during the study period; or a history of an intestinal disorder -
Sites / Locations
- Washington University in St. Louis
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Auto fecal microbitoa therapy
Saline enema
autologous fecal microbiota therapy
Saline enema